Childhood obesity

Laboratory Medicine

Volumn 37, Issue 5, 2006, Pages 298-305

  D'Amore, Paula J ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHER; PICRIC ACID;

ENVIRONMENTAL PROTECTION; HAZARDOUS WASTE; LABORATORY; REVIEW; UNITED STATES;

EID: 33646359483     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/7L4RBMVKM4UCDT06     Document Type: Review

References (91)

1. Prevalence of overweight and obesity among adults: Unites States, 1999-2002. National Center For Health Statistics. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/obese/obse99.htm. Accessed on February 8, 2006.
2. Global strategy on diet, physical activity and health. World Health Organization. Available at: http://www.who.int/dietphysicalactivity/ publications/facts/obesity/en/. Accessed on February 8, 2006.
3. Koplan JP, Liverman CT, Kraak V, eds. Preventing Childhood Obesity: Health in the Balance. Washington, DC: National Academic Press, 2005.
4. Finklestein E, Fiebelkorn I, Wang G. National medical spending attributable to overweight and obesity: How much and who's paying? Health Aff. 2003;22:219-226.
5. st century. Obstet Gynecol Surv. 2005;60:450-452.
6. Pietrobelli A, Faith MS, Allison DB, et al. Body mass index as a measure of adiposity among children and adolescents: A validation study. J Pediatr. 1998;132:204-210.
7. World Health Organization. Obesity: preventing and managing the global epidemic Report of a WHO consultation on obesity. Geneva: World Health Organization, 1998.
8. NHANES 2000 CDC Growth Charts: United States. Available at: http://www.cdc.gov/growthcharts/. Accessed on February 8, 2006.
9. NHANES 1999-2002, Prevalence of overweight among children and adolescents: United States, 1999-2002. National Center for Health Statistics. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/obese/obse99. htm. Accessed on February 8, 2006.
10. Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288:1728-1732.
11. Freedman DS, Srinivasan SR, Valdez RA, et al. Secular increases in relative weight and adiposity among children over two decades: The Bogalusa Heart Study. Pediatrics. 1997;99:420-426.
12. Freedman DS, Kettel-Khan L, Srinivasan SR, et al. Black/white differences in relative weight among girls: The Bogalusa Heart Study. Prev Med. 2000;30:234-243.
13. Dietz WH, Gortmaker SL. Preventing obesity in children and adolescents. Annu Rev Public Health. 2001;22:337-353.
14. Rosenbaum M, Leibel RL, Hirsch J. Medical progress: Obesity. NEJM. 1997;337:396-408.
15. Hill J, Throwbridge F. The causes and health consequences of obesity in children and adolescents. Pediatrics. 1998;101:497-575.
16. Neel JV. Diabetes mellitus: A "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962;14:353-362.
17. Chagnon YC, Pérusse L, Weisnagel SJ, et al. The human obesity gene map: The 1999 update. Obes Res. 2000;8:89-117.
18. Raniken T, Pérusse L, Weisnagel SJ, et al. The human obesity gene map: The 2001 update. Obes Res. 2002;10:196-243.
19. Pérusse L, Rankinen T, Zuberi A, et al. The human obesity gene map: The 2004 update. Obes Res. 2005;13:381-490.
20. Stunkard AJ, Sorenson TI, Harris C, et al. An adoption study of human obesity. NEJM. 1986;314:193-198.
21. Sorensen TI, Price RA, Stunkard AJ, et al. Genetics of obesity in adult adoptees and their biological siblings. BMJ. 1989;298:87-90.
22. Barsh GS, Farooqi IS, O'Rahilly S. Genetics of body-weight regulation. Nature. 2000;404:644-651.
23. Stunkard AJ, Harris JR, Pedersen NL, et al. The body-mass index of twins who have been reared apart. NEJM. 1990;322:1483-1487.
24. Lobstein T, Baur L, Uauy R. Obesity in children and young people: A crisis in public health. Obesity Reviews. 2004;5(Suppl 1):4-85.
25. Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood and parental obesity. NEJM. 1997;337:869-873.
26. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 2000;106:271-279.
27. Dietz WH. Critical periods in childhood for the development of obesity. Am J Clin Nutr. 1994;59:955-959.
28. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. NEJM. 1976;295:349-353.
29. Ericksson J, Forsen T, Tuomilehto J, et al. Early growth and coronary heart disease in later life: Longitudinal study. BMJ. 2001;322:949-953.
30. Fall C, Osmond C, Barker D, et al. Fetal and infant growth and cardiovascular risk factors in women. BMJ. 1995;310:428-432.
31. Whitaker RC, Dietz WH. Role of the prenatal environment in the development of obesity. J Pediatr. 1998;132:768-776.
32. Curhan GC, Chertow GM, Willett WC, et al. Birth weight and adult hypertension and obesity in women. Circulation. 1996;94:1310-1315.
33. Curhan GC, Willett WC, Rimm EB, et al. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996;94:3246-3250.
34. Martorell R, Stein AD, Schroeder DG. Early nutrition and later adiposity. J Nutr. 2001;131:874S-880S.
35. Dietz WH. Overweight in childhood and adolescence. NEJM. 2004;350:855-857.
36. Whitaker RC, Dietz WH. Adiposity rebound and the risk of adult obesity. Pediatrics. 1998;101:1-6.
37. Prokopec M, Bellisle F. Adiposity in Czech children followed from 1 month of age to adulthood: analysis of individual BMI patterns. Ann Hum Biol. 1993;20:517-525.
38. Freedman DS, Khan LK, Serdula MK, et al. BMI rebound, childhood height and obesity among adults: The Bogalusa Heart Study. Int J Obes Res. 2001;25:543-549.
39. Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood and parental obesity. NEJM. 1997;337:869-873.
40. Cummings DE, Scheartz MW. Genetics and pathophysiology of human obesity. Ann Rev Med. 2003;54:453-471.
41. Jackson RS, Creemers JW, Ohagi S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 1997;16:303-306.
42. Woods SC. Gastrointestinal Satiety Signals. I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol. 2004;286:G7-G13.
43. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth hormone-releasing acylated peptide from the stomach. Nature. 1999;402:656-660.
44. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. NEJM. 2002;346:1623-1630.
45. Cummings DE, Clement K, Puraell JQ, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nature Med. 2002;8:643-644.
46. Tsao TS, Lodish HF, Fruebis J. ACRP 30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol. 2002;440:213-221.
47. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrarions in women with dyslipidemia. J Clin Endocrinol Metab. 2002;87:2764-2769.
48. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease af an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
49. Hota K, Funahashi T, Arita Y, et al. Plasma concentrarions of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Thromb Vasc Biol. 2000;20:1595-1599.
50. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, Adiponectin. J Clin Endocrinol Metab. 2001;86:3815-3819.
51. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432.
52. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leprin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387:903-908.
53. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. NEJM. 1999;341:879-884.
54. Considine RY Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. NEJM. 1996;334:292-295.
55. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leprin and ob RNA in obese and weight-reduced subjects. Nature Med. 1995;1:1155-1161.
56. Boden G, Chen X, Mozzoli M, et al. Effect of fasting on serum leprin in normal human subjects. J Clin Endocrinol Metab. 1996;81:3419-3423.
57. Chin-Chance C, Polonsky KS, Schoeller DA. Twenty-four-hour leptin levels respond to cumulative short-term energy imbalance and predict subsequent intake. J Clin Endocrinol Metab. 2000;85:2685-2691.
58. Patrick K, Norman GJ, Calfas KJ, et al. Diet, physical activity, and sedentary behaviors as risk factors for overweight in adolescence. Arch Pediatr Adolesc Med. 2004;158:385-390.
59. Parsons TJ, Manor O, Power C. Changes in diet and physical activity in the 1990s in a large British sample (1958 birth cohort). Eur J Clin Nutrit. 2005;59:49-56.
60. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science. 1998;280:1371-1374.
61. Hernández B, Gortmaker SL, Colditz GA, et al. Association of obesity with physical activity, television programs and other forms of video viewing among children in Mexico City. Int J Obesity. 1999;23:845-854.
62. Andersen RE, Crespo CJ, Bartlett SJ, et al. Relationship of physical activity and television watching with body weight and level of fatness among children. JAMA. 1998;279:938-942.
63. Salbe A, Weyer C, Lindsay RS, et al. Assessing risk factors for obesity between childhood and adolescence: I. birth weight, childhood adiposity, parental, obesity, insulin and leptin. Pediatrics. 2002:110:299-307.
64. Weiss R, Dziura J, Burgert T, et al. Obesity and the metabolic syndrome in children and adolescents. NEJM. 2003;350:2362-2374.
65. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA. 2001;285:2486-2497.
66. de Ferranti SD, Gauvreau K, Ludwig DS, et al. Prevalence of the metabolic syndrome in American adolescents: Findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494-2497.
67. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428.
68. Lang CH, Dobrescu C, Bafby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992;130:43-52.
69. Feingold KR, Serio MK, Adi S, et al. Tumor necrosis factor stimulates hepatic lipids synthesis and secretion. Endocrinology. 1989;124:2336-2342.
70. Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents. Pathophysiology, consequences, prevention and treatment. Circulation. 2005;111:1999-2012.
71. Bergman RN, Prager G, Volund A, et al. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987;79:790-800.
72. Katz A, Mambi SS, Mather K, et al. Quantitative insulin-sensitivity check: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410.
73. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 2000;28:412-419.
74. National Diabetes Surveillance System. Prevalence of diabetes. Number (in millions) of persons with diagnosed diabetes, United States, 1980-2003 Available at: http://www.cdc.gov/diabetes/statistics/prev/national/figpersons. htm. Accessed on February 8, 2006.
75. American Diabetes Association. Diabetes statistics for youth. Available at: http://www.diabetes.org/diabetes-statistics/children.jsp. Accessed on February 8, 2006.
76. Fagot-Campagna A, Petit DJ, Engelgau MM. Type 2 diabetes among North American children and adolescents: An epidemiological review and a public health perpective. J Pediatrics. 2000;136:664-672.
77. American Diabetes Association consensus statement. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23:381-389.
78. Kinugasa A, Tsunamoto K, Furukawa N, et al. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr. 1984;3:408-414.
79. McCullough AJ. An update on nonalcoholic fatty liver disease. J Clin Gastroenterol. 2002;34:255-262.
80. Franzese A, Vajro P, Aregenziana A, et al. Liver involvement in obese children: Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci. 1997;42:1428-1432.
81. Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation. 2004;110:2952-2967.
82. Rocchini AP. Hemodynamic and cardiac consequences of childhood obesity. Ann NY Acad Sci. 1993;699:46-56.
83. Freedman DS, Dietz WH, Srinivasan SR, et al. The relation of overweight to cardiovascular risk factors among children and adolescents: Bogalusa Heart Study. Pediatrics. 1999;103:1175-1182.
84. Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: The Bogalusa Heart Study. JAMA. 2003;290:2271-2276.
85. McGill HC, McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712-2718.
86. Must A, Jacques PF, Dallal GE, et al. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. NEJM. 1992;327:1350-1355.
87. Yudkin JS, Stehouwer CDA, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 1999;19:972-978.
88. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-334.
89. Ryan AS, Nicklas BJ. Reductions in plasma cytokine levels with weight loss improves insulin sensitivity in overweight and obese postmenopausal women. Diab Care. 2004;27:1699-1705.
90. Haffner S, Greenberg AS, Weston WM, et al. Effects of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation. 2002;106:679-684.
91. American Diabetes Association. Standards of medical care in diabetes. Diab Care. 2005;28:S1-S36.